The structure of raloxifene
Find information on thousands of medical conditions and prescription drugs.

Evista

Raloxifene is an oral selective estrogen receptor modulator which is used in the prevention of osteoporosis in postmenopausal women. There has been some evidence that raloxifene can reduce the incidence of breast cancer, but this has yet to be proven in a clinical setting. Raloxifene is produced by Eli Lilly Pharmaceuticals and is sold under the brand name Evista.

SERMs mimic estrogen in some tissues and have anti-estrogen activity in others. Other SERMs, such as Pfizer's lasofoxifene and Wyeth's bazedoxifene are in the late stages of clinical development.

 Home
Diseases
Medicines
A
B
C
D
E
E-Base
Ecstasy (drug)
Edecrin
Edrophonium
Edrophonium chloride
Efavirenz
Effexor
Eflornithine
Elavil
Eldepryl
Elidel
Eligard
Elitek
Elixomin
Elixophyllin
Ellagic acid
Elmiron
Eloxatin
Elspar
Emtriva
Emylcamate
Enalapril
Enalaprilat
Enalaprilat
Endep
Enflurane
Enoxaparin sodium
Entacapone
Enulose
Epi-pen
Epinephrine
Epirubicin
Epitol
Epivir
Epogen
Eprosartan
Ergocalciferol
Ergoloid Mesylates
Ergotamine
Eryc
Eryped
Erythromycin
Esgic
Eskalith
Esmolol
Estazolam
Estazolam
Estrace
Estraderm
Estradiol
Estradiol
Estradiol valerate
Estring
Estrogel
Estrone
Estrostep
Ethacridine
Ethambutol
Ethchlorvynol
Ethosuximide
Ethotoin
Etiracetam
Etodolac
Etopophos
Etoposide
Etorphine
Evista
Exelon
Exemestane
Hexal Australia
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Read more at Wikipedia.org
• [List your site here Free!]


Evista gets cardiac OK in JAMA - Pharmacy News Briefs - Raloxifene study links drug to decreased risk of heart attack - Brief Article
Evista gets cardiac OK in JAMA. (Pharmacy News Briefs).(Raloxifene study links drug to decreased risk of heart attack)
From Drug Store News, 3/4/02 by James Frederick
Barr seeks to intervene in Evista suit
Barr Laboratories is seeking to intervene in Zeneca Inc.'s federal lawsuit that charges Eli Lilly with promoting Evista for reducing the risk of breast ...
From Drug Store News, 4/26/99
Eli Lilly warns pharmacists about Evista o -E-Vista confusion
Eli Lilly and Co. has issued a warning to pharmacists regarding potential for errors in filling Evista prescriptions. Evista @ (raloxifene HCI) 60mg tablets, ...
From Drug Store News, 5/25/98 by Kendall Shaw
Fosamax … not so great at reducing hip fracture
The osteoporosis drug Fosamax has been on the market for ten years now. Merck promoted it heavily for the last decade by selling women the fear of a ...
From Healthfacts, 8/1/05
FDA steps up action against counterfeit drugs, warns US consumers against fake medicine from Mexico
The US Food and Drug Administration (Rockville, MD, www.fda.gov) released its annual report on May 18 explaining the agency's campaign against counterfeit ...
From Pharmaceutical Technology, 6/1/05 by Douglas McCormick
Raloxifene reduces the risk of breast cancer
Clinical Question: does raloxifene prevent breast cancer? Setting: Outpatient (any) Study Design: Randomized controlled trial (double-blinded) Allocation: Uncertain Synopsis: This study, th
From American Family Physician, 4/1/05 by Henry Barry
Un Quijano para el otro país
Debo expresar, antes que nada, que con regocijo damos inicio a este gran Encuentro de Revistas Culturales--Literarias Puertorriqueñas, encuentro de una magnitud que me parece no habíamos visto nunc
From Archipielago, 4/1/05 by Marcos Reyes Dávila
Big Question: Hormones, The
What are the options? Recent findings about the drawbacks to estrogen (ET) and estrogen/progestin therapy (Combined Hormone Therapy - CHT) make it more ...
From Friend Indeed, A, 3/1/05 by Cobb, Janine O'Leary

Home Contact Resources Exchange Links ebay